Instagram Post Misleads About Pfizer’s RSV Maternal Vaccine
Clinical trial data for Pfizer’s maternal vaccine to protect babies from RSV support the vaccine’s safety and efficacy, according to a vote by an FDA advisory committee. The FDA could soon approve the vaccine. But a popular social media post makes misleading claims about the trial findings.
The post Instagram Post Misleads About Pfizer’s RSV Maternal Vaccine appeared first on FactCheck.org.
Read More